Silence Therapeutics

RNS Announcement

RNS Number : 6423T

FTSE Russell

25 November 2021

Silence Therapeutics (UK): Constituent Deletion
Changes in FTSE UK Index Series

25 November 2021

Subject to the expected cancellation of trading on AIM for Silence Therapeutics (UK, constituent), please see details of affected indexes and effective dates below:

Index	Effective From Start of Trading
FTSE AIM UK 50 Index	30 November 2021
FTSE AIM 100 Index	30 November 2021
FTSE AIM All-Share Index	30 November 2021

For further information please contact FTSE Russell Client Services at [email protected] or call:

Australia	+1800 653 680
Hong Kong	+852 2164 3333
Japan	+81 3 4563 6346
London	+44 (0) 20 7866 1810
New York	+1866 551 0617

Alternatively please visit our website at www.ftserussell.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

FTSDKPBDPBDDCDB

RNS metadata

Title: Silence Therapeutics
Time: 17:30:12
Date: 25 Nov 2021
Category: Miscellaneous
ID: 6423T